Literature DB >> 14573363

Biological applications of protein transduction technology.

Panagiotis S Kabouridis1.   

Abstract

The impermeable nature of the cell membrane to peptides, proteins, DNA and oligonucleotides limits the therapeutic potential of these biological agents. However, the recent discovery of short cationic peptides that cross the plasma membrane efficiently is opening up new possibilities for the intracellular delivery of such agents. These peptides are commonly referred to as protein transduction domains (PTDs) and are successfully used to transport heterologous proteins, peptides and other types of cargo into cells. Several recent reports have used the membrane transducing technology in vivo to deliver biologically active cargo into various tissues. This review discusses the structure of the most commonly used PTDs and how their ability to transduce membranes is used to regulate biological functions. It also considers future directions and the potential of this technology to move from the laboratory into the clinic.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573363      PMCID: PMC2597147          DOI: 10.1016/j.tibtech.2003.09.008

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  74 in total

Review 1.  Protein transduction: unrestricted delivery into all cells?

Authors:  S R Schwarze; K A Hruska; S F Dowdy
Journal:  Trends Cell Biol       Date:  2000-07       Impact factor: 20.808

Review 2.  Messenger proteins: homeoproteins, TAT and others.

Authors:  A Prochiantz
Journal:  Curr Opin Cell Biol       Date:  2000-08       Impact factor: 8.382

3.  A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease.

Authors:  S M Fujihara; J S Cleaveland; L S Grosmaire; K K Berry; K A Kennedy; J J Blake; J Loy; B M Rankin; J A Ledbetter; S G Nadler
Journal:  J Immunol       Date:  2000-07-15       Impact factor: 5.422

4.  Translocation properties of novel cell penetrating transportan and penetratin analogues.

Authors:  M Lindgren; X Gallet; U Soomets; M Hällbrink; E Bråkenhielm; M Pooga; R Brasseur; U Langel
Journal:  Bioconjug Chem       Date:  2000 Sep-Oct       Impact factor: 4.774

5.  Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo.

Authors:  Z Mi; J Mai; X Lu; P D Robbins
Journal:  Mol Ther       Date:  2000-10       Impact factor: 11.454

6.  Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation.

Authors:  J B Rothbard; S Garlington; Q Lin; T Kirschberg; E Kreider; P L McGrane; P A Wender; P A Khavari
Journal:  Nat Med       Date:  2000-11       Impact factor: 53.440

7.  Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.

Authors:  M J May; F D'Acquisto; L A Madge; J Glöckner; J S Pober; S Ghosh
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

8.  The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters.

Authors:  P A Wender; D J Mitchell; K Pattabiraman; E T Pelkey; L Steinman; J B Rothbard
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

9.  Peptide-directed suppression of a pro-inflammatory cytokine response.

Authors:  X Y Liu; D Robinson; R A Veach; D Liu; S Timmons; R D Collins; J Hawiger
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

10.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

Authors:  N A Lissy; P K Davis; M Irwin; W G Kaelin; S F Dowdy
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

View more
  26 in total

1.  Construction of recombinant proteins for reprogramming of endangered Luxi cattle fibroblast cells.

Authors:  P F Hu; W J Guan; X C Li; Y H Ma
Journal:  Mol Biol Rep       Date:  2012-02-05       Impact factor: 2.316

2.  A new method for direct detection of the sites of actin polymerization in intact cells and its application to differentiated vascular smooth muscle.

Authors:  Hak Rim Kim; Paul C Leavis; Philip Graceffa; Cynthia Gallant; Kathleen G Morgan
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

Review 3.  Sophistication of foldamer form and function in vitro and in vivo.

Authors:  Arjel D Bautista; Cody J Craig; Elizabeth A Harker; Alanna Schepartz
Journal:  Curr Opin Chem Biol       Date:  2007-11-07       Impact factor: 8.822

4.  Polyarginine as a multifunctional fusion tag.

Authors:  Stephen M Fuchs; Ronald T Raines
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

5.  Polymeric linear Peptide chimeric vaccine-induced antimalaria immunity is associated with enhanced in vitro antigen loading.

Authors:  Luciana M Silva-Flannery; Monica Cabrera-Mora; Megan Dickherber; Alberto Moreno
Journal:  Infect Immun       Date:  2009-02-23       Impact factor: 3.441

Review 6.  Cell penetrating peptide inhibitors of nuclear factor-kappa B.

Authors:  J S Orange; M J May
Journal:  Cell Mol Life Sci       Date:  2008-11       Impact factor: 9.261

7.  Reduced infiltration and increased apoptosis of leukocytes at sites of inflammation by systemic administration of a membrane-permeable IkappaBalpha repressor.

Authors:  Nathan M Blackwell; Phupinder Sembi; Justine S Newson; Toby Lawrence; Derek W Gilroy; Panagiotis S Kabouridis
Journal:  Arthritis Rheum       Date:  2004-08

8.  Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability.

Authors:  Jennifer H Law; Yvonne Li; Karen To; Michelle Wang; Arezoo Astanehe; Karen Lambie; Jaspreet Dhillon; Steven J M Jones; Martin E Gleave; Connie J Eaves; Sandra E Dunn
Journal:  PLoS One       Date:  2010-09-10       Impact factor: 3.240

9.  Replacement of the C6ORF66 assembly factor (NDUFAF4) restores complex I activity in patient cells.

Authors:  Dana Marcus; Michal Lichtenstein; Ann Saada; Haya Lorberboum-Galski
Journal:  Mol Med       Date:  2013-07-24       Impact factor: 6.354

10.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.